ESH/LinkedIn
Apr 27, 2026, 15:38
Key Insights from ESHMPN 26 on Advances in MPN Management – ESH
The European School of Haematology (ESH) shared a post on LinkedIn:
“Today’s second ESHMPN 26 session chaired by Jean – Jacques Kiladjian (INSERM) focussed on MPN management.
Marta Sobas (Collegium Medicum Uniwersytetu Mikołaja Kopernika) on the role of interferons on haematological and molecular responses;
- Jennifer O’Sullivan (Guy’s and St Thomas’ NHS Foundation Trust) on new potential trial endpoints;
- Chloé James (CHU de Bordeaux) on how to prevent thrombosis and bleeding in MPN;
- Selected brief oral presentation by Chiara Carretta, (Centro di Medicina Estetica e Rigenerativa) on determinants of JAK inhibitor efficacy in myelofibrosis revealed by Multiomic Single-Cell Analysis
Stay tuned!
For a deeper insight, meet Marta Sobas, Jennifer O’Sullivan, or Chloé James at tomorrow’s meeting the expert session!”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management
-
Sep 29, 2026, 16:01Stephen Cornelissen: How Joining the Stem Cell Registry Can Save Patients with Blood Cancers